New Nordic Healthbrands Valuation
Is NNH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NNH?
Other financial metrics that can be useful for relative valuation.
| What is NNH's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | kr144.35m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.3x |
| Enterprise Value/EBITDA | 175.9x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does NNH's PE Ratio compare to its peers?
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 31.4x | ||
CLEM Clemondo Group | 17.7x | 36.0% | kr135.4m |
HUMBLE Humble Group | 89.6x | 75.0% | kr3.5b |
ERFO Laboratorio Farmaceutico Erfo | 15.4x | 27.7% | €11.0m |
MRAT Mustika Ratu | 2.9x | n/a | Rp192.6b |
NNH New Nordic Healthbrands | 123.2x | n/a | kr144.3m |
Price-To-Earnings vs Peers: NNH is expensive based on its Price-To-Earnings Ratio (123.2x) compared to the peer average (31.4x).
Price to Earnings Ratio vs Industry
How does NNH's PE Ratio compare vs other companies in the European Personal Products Industry?
Price-To-Earnings vs Industry: NNH is expensive based on its Price-To-Earnings Ratio (123.2x) compared to the European Personal Products industry average (30.7x).
Price to Earnings Ratio vs Fair Ratio
What is NNH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 123.2x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NNH's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of NNH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NNH (SEK23.3) is trading below our estimate of fair value (SEK64.33)
Significantly Below Fair Value: NNH is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.